Literature DB >> 4370014

Excretion of cyclic 3',5'-adenosine monophosphate in renal insufficiency and primary hyperparathyroidism after stimulation with parathyroid hormone.

H von Lilienfeld-Toal, R D Hesch, M Hüfner, C McIntosh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4370014     DOI: 10.1055/s-0028-1093837

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


× No keyword cloud information.
  7 in total

1.  Urinary cAMP activity in chronic renal failure.

Authors:  M Z Mocan; C Erem; S Ulusoy
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

2.  Osteoporosis: a bone turnover defect resulting from an elevated parathyroid hormone concentration within the bone-marrow cavity?

Authors:  M J Atkinson; T Schettler; H Bodenstein; R D Hesch
Journal:  Klin Wochenschr       Date:  1984-02-01

3.  Nephrogenous cyclic adenosine monophosphate as a parathyroid function test.

Authors:  A E Broadus; J E Mahaffey; F C Bartter; R M Neer
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

4.  Plasma 25-hydroxyvitamin D and urinary cyclic AMP in German patients with subtotal gastrectomy (Billroth II).

Authors:  H von Lilienfeld-Toal; K G Mackes; G Kodrat; H Ochs; A Sonnenberg
Journal:  Am J Dig Dis       Date:  1977-07

5.  Comparison of renal responses to synthetic human PTH(1-34) administration in normal young and elderly male subjects.

Authors:  S Imanaka; T Onishi; S Morimoto; S Takamoto; H Kohno; Y Kumahara
Journal:  Calcif Tissue Int       Date:  1985-07       Impact factor: 4.333

6.  Canine renal receptors for parathyroid hormone. Down-regulation in vivo by exogenous parathyroid hormone.

Authors:  C A Mahoney; R A Nissenson
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

7.  Rapid development of renal resistance to low doses of synthetic bovine parathyroid hormone fragment 1-34. Dissociation of urinary cyclic adenosine monophosphate, phosphaturic, and calciuric responses.

Authors:  W M Law; H Heath
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.